India  

WHO issues medical product alert on four cough syrups made by India's Maiden Pharmaceuticals

IndiaTimes Wednesday, 5 October 2022
The World Health Organization (WHO) on Wednesday issued a medical product alert on four cough and cold syrups made by India's Maiden Pharmaceuticals Ltd, potentially linking it to acute kidney injuries and 66 deaths among children in Gambia.WHO said it was conducting further investigation with the company and regulatory authorities in India.
0
shares
ShareTweetSavePostSend
 
Video Credit: Oneindia - Published
News video: WHO: 4 Indian cough syrups being probed after 66 children die in Gambia|Oneindia news *International

WHO: 4 Indian cough syrups being probed after 66 children die in Gambia|Oneindia news *International 02:22

The World Health Organisation on Wednesday warned that four "contaminated" and "substandard" cough syrups, allegedly produced by Maiden Pharmaceuticals Limited based in Haryana's Sonipat could be the reason for the deaths of at least 66 children in The Gambia. This has brought at least 4 cough syrups...

You Might Like


💡 newsR Knowledge: Other News Mentions

World Health Organization World Health Organization Specialized agency of the United Nations

WHO urges 'immediate action' after 300 cough syrup child deaths

The World Health Organisation (WHO) has called for "immediate and concerted action" after the deaths of more than 300 children were linked to contaminated cough..
Sky News
WHO recommends not using 2 Indian cough syrups in Uzbekistan | Oneindia News *News [Video]

WHO recommends not using 2 Indian cough syrups in Uzbekistan | Oneindia News *News

The World Health Organization (WHO) has recommended that two cough syrups made by Noida-based company Marion Biotech should not be used for children in Uzbekistan. The recommendation against the two cough syrups was issued in a medical product alert on Wednesday where th WHO said that the "substandard medical products", manufactured by Marion Biotech, "are products that fail to meet quality standards or specifications and are therefore out of specification." #WHO #Uzbekistan #IndianCoughSyrups

Credit: Oneindia    Duration: 02:17Published
WHO concerned about 'risk to life' in China amid COVID surge [Video]

WHO concerned about 'risk to life' in China amid COVID surge

The head of the World Health Organization said Wednesday the agency is “concerned about the risk to life in China” amid the coronavirus’ explosive spread across the country and the lack of outbreak data from the Chinese government.

Credit: euronews (in English)    Duration: 01:12Published
Did WHO term Covid-19 as the seasonal flu? Fact Check | Oneindia News *News [Video]

Did WHO term Covid-19 as the seasonal flu? Fact Check | Oneindia News *News

An old video is currently going viral on social media in which a group of scientists is seen calling Covid-19 as the seasonal flu, watch this video to know about the fact check of the video. #Covid-19 #WHO #FactCheck

Credit: Oneindia    Duration: 02:31Published

Related news from verified sources

With raids and show-cause notice, govt plans mega crackdown on cough syrup maker under WHO lens over Gambia deaths

The WHO warned that four cough syrups produced by Maiden Pharmaceuticals Limited could be the reason for the deaths of 66 children in The Gambia.
DNA Also reported by •Zee News

Haryana STOPS cough syrup production by Maiden Pharma linked to 66 child deaths in Gambia

Earlier on Monday, the Indian Pharma company had released a statement over the reports linking its cough syrups to the deaths of 66 children in Gambia.  
Zee News Also reported by •DNAIndiaTimes

Deaths linked to cough syrups: Govt panel says info shared by WHO so far inadequate

The committee set up by the government to examine reports potentially linking the death of 66 children in The Gambia to four made-in-India cough syrups has...
IndiaTimes Also reported by •Zee News